NovaBridge Biosciences (NBP) Net Income towards Common Stockholders Growth (1y) (2020 - 2025)
NovaBridge Biosciences (NBP) Net Income towards Common Stockholders Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
-58.11% |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
104.24% |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
-290.15% |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
-129.68% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
- |
| 10 |
NovaBridge Biosciences |
331.49 Mn |
120.65 Mn |
- |
-112.02% |
| Date | Value |
|---|
| Dec 31, 2025 |
-112.02% |
| Sep 30, 2025 |
66.68% |
| Jun 30, 2025 |
-121.91% |
| Mar 31, 2025 |
54.33% |
| Sep 30, 2024 |
-161.62% |
| Jun 30, 2024 |
140.88% |
| Dec 31, 2020 |
390.26% |
| Sep 30, 2020 |
-134.63% |
